NFE | ||
---|---|---|
OUTLOOK RATING 1..100 | 5 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 91 | |
PRICE GROWTH RATING 1..100 | 98 | |
P/E GROWTH RATING 1..100 | 73 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CGMS | NFE | |
---|---|---|
RSI ODDS (%) | 2 days ago31% | 2 days ago73% |
Stochastic ODDS (%) | 2 days ago41% | 2 days ago87% |
Momentum ODDS (%) | 3 days ago66% | 2 days ago65% |
MACD ODDS (%) | 2 days ago68% | 2 days ago70% |
TrendWeek ODDS (%) | 2 days ago71% | 2 days ago88% |
TrendMonth ODDS (%) | 2 days ago67% | 2 days ago89% |
Advances ODDS (%) | 3 days ago69% | 4 days ago79% |
Declines ODDS (%) | 9 days ago40% | 2 days ago87% |
BollingerBands ODDS (%) | 2 days ago42% | 2 days ago73% |
Aroon ODDS (%) | 2 days ago59% | N/A |
A.I.dvisor tells us that CGMS and DBD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGMS and DBD's prices will move in lockstep.
Ticker / NAME | Correlation To CGMS | 1D Price Change % | ||
---|---|---|---|---|
CGMS | 100% | -0.33% | ||
DBD - CGMS | 22% Poorly correlated | -0.14% | ||
NFE - CGMS | 15% Poorly correlated | -8.36% |